Alerts will be sent to your verified email
Verify EmailANTHEM
Anthem Biosciences
|
Syngene Internation.
|
Sai Life Sciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Unclassified
|
|||
R&D as a % of Total Sales
|
1.06 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
25.71 % | 12.33 % | 5.4 % |
5yr average Equity Multiplier
|
1.29 | 1.57 | 2.22 |
5yr Average Asset Turnover Ratio
|
0.7 | 0.52 | 0.51 |
5yr Avg Net Profit Margin
|
28.86 % | 15.3 % | 5.15 % |
Price to Book
|
17.2 | 5.99 | 7.71 |
P/E
|
91.84 | 55.8 | 96.44 |
5yr Avg Cash Conversion Cycle
|
95.96 Days | -6453.7 Days | -71.78 Days |
Inventory Days
|
34.24 Days | 20.52 Days | 32.4 Days |
Days Receivable
|
93.09 Days | 48.33 Days | 67.19 Days |
Days Payable
|
56.4 Days | -264.76 Days | 206.9 Days |
5yr Average Interest Coverage Ratio
|
48.04 | 16.15 | 2.83 |
5yr Avg ROCE
|
33.63 % | 13.11 % | 9.49 % |
5yr Avg Operating Profit Margin
|
39.0 % | 29.04 % | 18.59 % |
5 yr average Debt to Equity
|
0.08 | 0.15 | 0.7 |
5yr CAGR Net Profit
|
10.71 % | 4.15 % | 1.64 % |
5yr Average Return on Assets
|
19.71 % | 7.88 % | 2.64 % |
Shareholdings
|
|||
Promoter Holding
|
n/a | 52.68 % | 35.15 % |
Share Pledged by Promoters
|
n/a | 0.0 | 0.01 % |
Change in Promoter Holding (3 Yrs)
|
n/a | -17.61 % | -0.09 % |
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 17.91 % | 14.49 % |
Anthem Biosciences
|
Syngene Internation.
|
Sai Life Sciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|